KeyPlants’ Turnkey Life Science Facility Construction For Galderma

Magnusson advised Galderma on the deal.

The Swedish company KeyPlants has received a € 75M order from Galderma, the world’s largest independent global dermatological company, to build a life science facility in the city of Uppsala, Sweden. The new factory is being built to meet increasing global demand for Galderma’s products in aesthetic treatment.

Most of the plant will be built off-site in KeyPlants´ workshop in Vara, Sweden. KeyPlants will be responsible for the complete project including detailed design, ground works and construction on-site, off-site manufacturing, installation of all equipment, as well as qualification to ensure all process equipment works as planned.

KeyPlants, headquartered in Stockholm, Sweden, is a leader in the clean room manufacturing space for the life science industry, having executed 100+ projects globally.

The Magnusson team was led by Tobias Edenman (Picture). 

Involved fees earner: Tobias Edenman – Magnusson;

Law Firms: Magnusson;

Clients: Galderma Pharma;

Federica Tiefenthaler

Author: Federica Tiefenthaler